Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease
暂无分享,去创建一个
Bin Liu | Belinda Wilson | B. Liu | Jau-Shyong Hong | B. Wilson | Jau‐Shyong Hong | Wanqin Zhang | Wanqin Zhang | Hui-Ming Gao | Hui‐Ming Gao | Janwei Jiang | J. Jiang | Janwei Jiang | Hui-Ming Gao
[1] W. Foege,et al. 1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM , 1982, The Lancet.
[2] G. Levi,et al. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide , 1998, Progress in Neurobiology.
[3] S. Daniel,et al. Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[4] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[5] L. Swanson. The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .
[6] E. Hirsch,et al. FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells , 1999, The Journal of Neuroscience.
[7] T. Peng,et al. Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.
[8] S. Yang,et al. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. , 2000, The Journal of pharmacology and experimental therapeutics.
[9] W. Tatton,et al. Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.
[10] Stanley J. Watson,et al. The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.
[11] P. Kidd,et al. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. , 2000, Alternative medicine review : a journal of clinical therapeutic.
[12] M. Vawter,et al. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. , 1996, Experimental neurology.
[13] P C O'Brien,et al. Brain injury and neurologic sequelae , 1991, Neurology.
[14] J. Farber,et al. Mechanisms of cell injury by activated oxygen species. , 1994, Environmental health perspectives.
[15] I. Pérez-Otaño,et al. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures , 1995, Brain Research.
[16] F. Aloisi,et al. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. , 1999, Advances in experimental medicine and biology.
[17] H. Mori. [Postencephalitic parkinsonism]. , 1999, Ryoikibetsu shokogun shirizu.
[18] S. Yang,et al. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. , 2001, The Journal of pharmacology and experimental therapeutics.
[19] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[20] E. Hirsch,et al. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[22] M. Marmot,et al. Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[23] W. Weiner,et al. Trauma as an etiology of parkinsonism: A historical review of the concept , 1988, Movement disorders : official journal of the Movement Disorder Society.
[24] Jau-Shyong Hong,et al. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures , 1998, Journal of Neuroimmunology.
[25] E. Hirsch. Glial cells and Parkinson’s disease , 2000, Journal of Neurology.
[26] INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .
[27] J. Cano,et al. The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic System , 2000, Neurobiology of Disease.
[28] P. Jenner,et al. Understanding cell death in parkinson's disease , 1998, Annals of neurology.
[29] M. Vawter,et al. TGFβ1 and TGFβ2 Concentrations Are Elevated in Parkinson's Disease in Ventricular Cerebrospinal Fluid , 1996, Experimental Neurology.
[30] Bin Liu,et al. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. , 2000, The Journal of pharmacology and experimental therapeutics.
[31] Y. Hannun,et al. Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death* , 1998, The Journal of Biological Chemistry.
[32] M. Yahr,et al. Postencephalitic parkinsonism – a review , 1998, Journal of Neural Transmission.
[33] J. Stolk,et al. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. , 1994, American journal of respiratory cell and molecular biology.
[34] M. Polymeropoulos. Autosomal dominant Parkinson’s disease , 1998, Journal of Neurology.
[35] N. Wood,et al. The genetics of Parkinson's disease. , 2000, Current opinion in genetics & development.
[36] V. Perry,et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain , 1990, Neuroscience.
[37] P. Dobrzanski,et al. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.
[38] B. Babior. NADPH oxidase: an update. , 1999, Blood.
[39] J. Mong,et al. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures , 1994, Neuropharmacology.
[40] J. Rogers,et al. A Perspective on Inflammation in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[41] B. Liu,et al. Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2002, The Journal of Neuroscience.
[42] D. Dickson,et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.
[43] C. Raine,et al. Multiple sclerosis: immune system molecule expression in the central nervous system. , 1994, Journal of neuropathology and experimental neurology.
[44] T. Dawson,et al. Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.
[45] W. Streit,et al. Microglial Response to Brain Injury: A Brief Synopsis , 2000, Toxicologic pathology.
[46] J. Cano,et al. Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System , 1998, Journal of neurochemistry.
[47] T. Molitor,et al. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.
[48] G. Bing,et al. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats , 2000, Neuroscience.
[49] P. Carvey,et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain , 2002, Movement disorders : official journal of the Movement Disorder Society.
[50] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[51] C. Fall,et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.
[52] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[53] G. Baltuch,et al. Microglia as mediators of inflammatory and degenerative diseases. , 1999, Annual review of neuroscience.
[54] Jau-Shyong Hong,et al. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis , 2001, Journal of neurochemistry.
[55] B. Babior. NADPH Oxidase: An Update , 1999 .
[56] B. Liu,et al. Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration , 2002, Annals of the New York Academy of Sciences.
[57] James P. O'Callaghan,et al. Brain injury in a dish: a model for reactive gliosis , 1994, Trends in Neurosciences.
[58] J. Guralnik,et al. Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.
[59] R. Mohney,et al. Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.
[60] V. Massey. The microestimation of succinate and the extinction coefficient of cytochrome c. , 1959, Biochimica et biophysica acta.